CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 204 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $158,987 | +160.6% | 7,828 | +183.2% | 0.00% | – |
Q2 2021 | $61,000 | -30.7% | 2,764 | -62.8% | 0.00% | -100.0% |
Q1 2020 | $88,000 | -70.0% | 7,437 | -64.1% | 0.00% | -50.0% |
Q3 2019 | $293,000 | -40.4% | 20,701 | -50.6% | 0.00% | -60.0% |
Q1 2019 | $492,000 | +53.8% | 41,937 | +115.8% | 0.01% | +66.7% |
Q1 2018 | $320,000 | +290.2% | 19,429 | +180.5% | 0.00% | +200.0% |
Q2 2017 | $82,000 | +95.2% | 6,926 | -10.0% | 0.00% | – |
Q2 2016 | $42,000 | -27.6% | 7,699 | -37.4% | 0.00% | -100.0% |
Q1 2016 | $58,000 | +87.1% | 12,304 | +95.2% | 0.00% | – |
Q4 2015 | $31,000 | +3000.0% | 6,304 | +1776.2% | 0.00% | – |
Q3 2015 | $1,000 | -97.5% | 336 | -94.9% | 0.00% | -100.0% |
Q2 2015 | $40,000 | +73.9% | 6,636 | +61.9% | 0.00% | – |
Q1 2015 | $23,000 | +1050.0% | 4,100 | +485.7% | 0.00% | – |
Q4 2014 | $2,000 | -88.9% | 700 | -89.4% | 0.00% | – |
Q3 2014 | $18,000 | -72.3% | 6,593 | -71.5% | 0.00% | -100.0% |
Q2 2014 | $65,000 | -66.7% | 23,109 | -48.2% | 0.00% | -66.7% |
Q1 2014 | $195,000 | – | 44,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |